BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuna AT. Serological markers of inflammatory bowel disease. Biochem Med (Zagreb). 2013;23:28-42. [PMID: 23457764 DOI: 10.11613/BM.2013.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Ranjbar R, Ghasemian M, Maniati M, Hossein Khatami S, Jamali N, Taheri-anganeh M. Gastrointestinal disorder biomarkers. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.02.013] [Reference Citation Analysis]
2 Lew D, Yoon SM, Yan X, Robbins L, Haritunians T, Liu Z, Li D, McGovern DP. Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients. World J Gastroenterol 2017; 23(40): 7265-7273 [PMID: 29142473 DOI: 10.3748/wjg.v23.i40.7265] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 Tang J, Yang Q, Huang Z, Guo H, Chao K, Hu P, Gao X. Early serum infliximab trough level and mucosal healing could be predictors for one-year outcome after initiating therapy in Crohn's disease. Scand J Gastroenterol 2020;55:1035-40. [PMID: 32819192 DOI: 10.1080/00365521.2020.1800077] [Reference Citation Analysis]
4 Wylezinski LS, Gray JD, Polk JB, Harmata AJ, Spurlock CF 3rd. Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. J Clin Med 2019;8:E493. [PMID: 30979036 DOI: 10.3390/jcm8040493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 阮慧杰, 许翠萍. IBD血清学标志物的临床应用前景. 世界华人消化杂志 2017; 25(19): 1728-1734 [DOI: 10.11569/wcjd.v25.i19.1728] [Reference Citation Analysis]
6 Vojdani A, Vojdani E, Herbert M, Kharrazian D. Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA. Int J Mol Sci 2020;21:E1381. [PMID: 32085663 DOI: 10.3390/ijms21041381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Estruch J, Johnson J, Ford S, Yoshimoto S, Mills T, Bergman P. Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs. J Vet Intern Med 2021;35:1306-15. [PMID: 33960552 DOI: 10.1111/jvim.16132] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ahmed I, Roy BC, Khan SA, Septer S, Umar S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms. 2016;4:20. [PMID: 27681914 DOI: 10.3390/microorganisms4020020] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 10.8] [Reference Citation Analysis]
9 Kuna AT, Đerek L, Kozmar A, Drvar V. Current practice in laboratory diagnostics of autoimmune diseases in Croatia. 
Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb) 2016;26:376-94. [PMID: 27812306 DOI: 10.11613/BM.2016.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Kyriakidi KS, Tsianos VE, Karvounis E, Christodoulou DK, Katsanos KH, Tsianos EV. Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases. Ann Gastroenterol 2016;29:258-67. [PMID: 27366026 DOI: 10.20524/aog.2016.0028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
12 Li D, Haritunians T, Landers C, Potdar AA, Yang S, Huang H, Schumm LP, Daly M, Targan SR, McGovern DPB. Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics. Inflamm Bowel Dis 2018;24:2413-22. [PMID: 29860388 DOI: 10.1093/ibd/izy148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
13 Wang ZZ, Shi K, Peng J. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype. Biomed Rep 2017;6:401-10. [PMID: 28413638 DOI: 10.3892/br.2017.860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
14 Estruch JJ, Barken D, Bennett N, Krawiec DK, Ogilvie GK, Powers BE, Polansky BJ, Sueda MT. Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease. J Vet Intern Med 2020;34:1177-86. [PMID: 32282988 DOI: 10.1111/jvim.15761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Longo S, Chieppa M, Cossa LG, Spinelli CC, Greco M, Maffia M, Giudetti AM. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020;8:18. [PMID: 32784952 DOI: 10.3390/proteomes8030018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang JQ, Huang Y. Serological markers of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4110-4115 [DOI: 10.11569/wcjd.v21.i36.4110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Imakiire S, Takedatsu H, Mitsuyama K, Sakisaka H, Tsuruta K, Morita M, Kuno N, Abe K, Funakoshi S, Ishibashi H, Yoshioka S, Torimura T, Hirai F. Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis. Gut Liver 2022;16:92-100. [PMID: 35027509 DOI: 10.5009/gnl210211] [Reference Citation Analysis]
18 Tetangco EP, Stein AC. Medical Treatment of Intestinal Crohn's disease. Seminars in Colon and Rectal Surgery 2022. [DOI: 10.1016/j.scrs.2022.100862] [Reference Citation Analysis]
19 Takahashi N, Kitazawa C, Itani Y, Awaga Y, Hama A, Hayashi I, Takamatsu H. Exploratory clinical characterization of experimentally-induced ulcerative colitis nonhuman primates. Heliyon 2020;6:e03178. [PMID: 31938753 DOI: 10.1016/j.heliyon.2020.e03178] [Reference Citation Analysis]
20 Wasinger VC, Yau Y, Duo X, Zeng M, Campbell B, Shin S, Luber R, Redmond D, Leong RW. Low mass blood peptides discriminative of inflammatory bowel disease (IBD) severity: A quantitative proteomic perspective. Mol Cell Proteomics. 2016;15:256-265. [PMID: 26530476 DOI: 10.1074/mcp.m115.055095] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
21 Castro-Dopico T, Clatworthy MR. IgG and Fcγ Receptors in Intestinal Immunity and Inflammation. Front Immunol 2019;10:805. [PMID: 31031776 DOI: 10.3389/fimmu.2019.00805] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
22 Trejo-Vazquez F, Garza-Veloz I, Villela-Ramirez GA, Ortiz-Castro Y, Mauricio-Saucedo P, Cardenas-Vargas E, Diaz-Baez M, Cid-Baez MA, Castañeda-Miranda R, Ortiz-Rodriguez JM, Solis-Sanchez LO, Martinez-Fierro ML. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study. Exp Ther Med 2018;15:3336-44. [PMID: 29545852 DOI: 10.3892/etm.2018.5835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Guo S, Lu Y, Xu B, Wang W, Xu J, Zhang G. A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease. Front Microbiol. 2019;10:1306. [PMID: 31244813 DOI: 10.3389/fmicb.2019.01306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
24 Williams SC, Frew JW, Krueger JG. A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa. Exp Dermatol 2021;30:1388-97. [PMID: 32614993 DOI: 10.1111/exd.14141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Yao F, Fan Y, Lv B, Ji C, Xu L. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study. Medicine (Baltimore) 2018;97:e11772. [PMID: 30095633 DOI: 10.1097/MD.0000000000011772] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Lee DS, Lee KL, Jeong JB, Shin S, Kim SH, Kim JW. Expression of Chemokine CCL28 in Ulcerative Colitis Patients. Gut Liver 2021;15:70-6. [PMID: 32102131 DOI: 10.5009/gnl19273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Actis GC, Pellicano R, Rosina F. Inflammatory bowel disease: Traditional knowledge holds the seeds for the future. World J Gastrointest Pharmacol Ther 2015; 6(2): 10-16 [PMID: 25949845 DOI: 10.4292/wjgpt.v6.i2.10] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Chen P, Zhou G, Lin J, Li L, Zeng Z, Chen M, Zhang S. Serum Biomarkers for Inflammatory Bowel Disease. Front Med (Lausanne). 2020;7:123. [PMID: 32391365 DOI: 10.3389/fmed.2020.00123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
29 Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]